BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18339857)

  • 1. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.
    Hatton BA; Villavicencio EH; Tsuchiya KD; Pritchard JI; Ditzler S; Pullar B; Hansen S; Knoblaugh SE; Lee D; Eberhart CG; Hallahan AR; Olson JM
    Cancer Res; 2008 Mar; 68(6):1768-76. PubMed ID: 18339857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.
    Hekmatyar SK; Wilson M; Jerome N; Salek RM; Griffin JL; Peet A; Kauppinen RA
    Br J Cancer; 2010 Oct; 103(8):1297-304. PubMed ID: 20842126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile.
    Malawsky DS; Weir SJ; Ocasio JK; Babcock B; Dismuke T; Cleveland AH; Donson AM; Vibhakar R; Wilhelmsen K; Gershon TR
    Commun Biol; 2021 May; 4(1):616. PubMed ID: 34021242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.
    Garzia L; Kijima N; Morrissy AS; De Antonellis P; Guerreiro-Stucklin A; Holgado BL; Wu X; Wang X; Parsons M; Zayne K; Manno A; Kuzan-Fischer C; Nor C; Donovan LK; Liu J; Qin L; Garancher A; Liu KW; Mansouri S; Luu B; Thompson YY; Ramaswamy V; Peacock J; Farooq H; Skowron P; Shih DJH; Li A; Ensan S; Robbins CS; Cybulsky M; Mitra S; Ma Y; Moore R; Mungall A; Cho YJ; Weiss WA; Chan JA; Hawkins CE; Massimino M; Jabado N; Zapotocky M; Sumerauer D; Bouffet E; Dirks P; Tabori U; Sorensen PHB; Brastianos PK; Aldape K; Jones SJM; Marra MA; Woodgett JR; Wechsler-Reya RJ; Fults DW; Taylor MD
    Cell; 2018 Feb; 172(5):1050-1062.e14. PubMed ID: 29474906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptomeningeal metastases: how best to assess response.
    Chamberlain MC
    Neuro Oncol; 2020 Oct; 22(10):1417-1418. PubMed ID: 32770188
    [No Abstract]   [Full Text] [Related]  

  • 6. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
    Fults DW; Taylor MD; Garzia L
    J Neurosurg Pediatr; 2019 Feb; 23(5):613-621. PubMed ID: 30771762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
    Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
    Cell Rep; 2021 Jul; 36(4):109475. PubMed ID: 34320362
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered neural cell fates and medulloblastoma in mouse patched mutants.
    Goodrich LV; Milenković L; Higgins KM; Scott MP
    Science; 1997 Aug; 277(5329):1109-13. PubMed ID: 9262482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.
    Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U
    Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertumoral Heterogeneity within Medulloblastoma Subgroups.
    Cavalli FMG; Remke M; Rampasek L; Peacock J; Shih DJH; Luu B; Garzia L; Torchia J; Nor C; Morrissy AS; Agnihotri S; Thompson YY; Kuzan-Fischer CM; Farooq H; Isaev K; Daniels C; Cho BK; Kim SK; Wang KC; Lee JY; Grajkowska WA; Perek-Polnik M; Vasiljevic A; Faure-Conter C; Jouvet A; Giannini C; Nageswara Rao AA; Li KKW; Ng HK; Eberhart CG; Pollack IF; Hamilton RL; Gillespie GY; Olson JM; Leary S; Weiss WA; Lach B; Chambless LB; Thompson RC; Cooper MK; Vibhakar R; Hauser P; van Veelen MC; Kros JM; French PJ; Ra YS; Kumabe T; López-Aguilar E; Zitterbart K; Sterba J; Finocchiaro G; Massimino M; Van Meir EG; Osuka S; Shofuda T; Klekner A; Zollo M; Leonard JR; Rubin JB; Jabado N; Albrecht S; Mora J; Van Meter TE; Jung S; Moore AS; Hallahan AR; Chan JA; Tirapelli DPC; Carlotti CG; Fouladi M; Pimentel J; Faria CC; Saad AG; Massimi L; Liau LM; Wheeler H; Nakamura H; Elbabaa SK; Perezpeña-Diazconti M; Chico Ponce de León F; Robinson S; Zapotocky M; Lassaletta A; Huang A; Hawkins CE; Tabori U; Bouffet E; Bartels U; Dirks PB; Rutka JT; Bader GD; Reimand J; Goldenberg A; Ramaswamy V; Taylor MD
    Cancer Cell; 2017 Jun; 31(6):737-754.e6. PubMed ID: 28609654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma: toward biologically based management.
    Samkari A; White JC; Packer RJ
    Semin Pediatr Neurol; 2015 Mar; 22(1):6-13. PubMed ID: 25976255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
    Yauch RL; Dijkgraaf GJ; Alicke B; Januario T; Ahn CP; Holcomb T; Pujara K; Stinson J; Callahan CA; Tang T; Bazan JF; Kan Z; Seshagiri S; Hann CL; Gould SE; Low JA; Rudin CM; de Sauvage FJ
    Science; 2009 Oct; 326(5952):572-4. PubMed ID: 19726788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
    Northcott PA; Lee C; Zichner T; Stütz AM; Erkek S; Kawauchi D; Shih DJ; Hovestadt V; Zapatka M; Sturm D; Jones DT; Kool M; Remke M; Cavalli FM; Zuyderduyn S; Bader GD; VandenBerg S; Esparza LA; Ryzhova M; Wang W; Wittmann A; Stark S; Sieber L; Seker-Cin H; Linke L; Kratochwil F; Jäger N; Buchhalter I; Imbusch CD; Zipprich G; Raeder B; Schmidt S; Diessl N; Wolf S; Wiemann S; Brors B; Lawerenz C; Eils J; Warnatz HJ; Risch T; Yaspo ML; Weber UD; Bartholomae CC; von Kalle C; Turányi E; Hauser P; Sanden E; Darabi A; Siesjö P; Sterba J; Zitterbart K; Sumerauer D; van Sluis P; Versteeg R; Volckmann R; Koster J; Schuhmann MU; Ebinger M; Grimes HL; Robinson GW; Gajjar A; Mynarek M; von Hoff K; Rutkowski S; Pietsch T; Scheurlen W; Felsberg J; Reifenberger G; Kulozik AE; von Deimling A; Witt O; Eils R; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Korbel JO; Wechsler-Reya RJ; Pfister SM
    Nature; 2014 Jul; 511(7510):428-34. PubMed ID: 25043047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of stem cells and progenitors in the genesis of medulloblastoma.
    Wang J; Wechsler-Reya RJ
    Exp Neurol; 2014 Oct; 260():69-73. PubMed ID: 23178582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies.
    Holmberg KO; Borgenvik A; Zhao M; Giraud G; Swartling FJ
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-fraction Radiation Treatment Dose Response in a Genetically Engineered Mouse Model of Medulloblastoma.
    Tu KJ; Stewart CE; Williams NT; Ma Y; Luo L; Ghosh D; Weidenhammer LB; Floyd SR; Fan Y; Kirsch DG; Oldham M; Reitman ZJ
    Radiat Res; 2023 Dec; 200(6):587-592. PubMed ID: 37990957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
    Mishra DK; Popovski D; Morris SM; Bondoc A; Senthil Kumar S; Girard EJ; Rutka J; Fouladi M; Huang A; Olson JM; Drissi R
    Neuro Oncol; 2024 Feb; 26(2):226-235. PubMed ID: 37713135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond.
    Petroni M; La Monica V; Fabretti F; Augusto M; Battaglini D; Polonara F; Di Giulio S; Giannini G
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure.
    Pallavicini G; Iegiani G; Parolisi R; Ferraro A; Garello F; Bitonto V; Terreno E; Gai M; Di Cunto F
    Front Oncol; 2023; 13():1202585. PubMed ID: 37404750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.